HOXD10 has been widely acknowledged as a tumor suppressor and has been observed to be downregulated in various cancer types, including colon carcinomas, early-stage head and neck squamous cell carcinoma, and oral squamous cell carcinoma [31,32]. This evidence concerns the gene HOXD10 and neoplasm.